Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Veeva Systems Inc.

Veeva provides software, data, and business consulting for research and development, quality, and commercial operations in the life sciences industry.

Veeva

Generation Veeva

Veeva Consumer Products

Veeva Systems APAC

Veeva MedTech

Veeva Crossix

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 875 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Canada, Europe, Asia, and Latin America. Visit the Jobs section for open positions and remember that correspondence to new applicants and existing candidates will only come from an official @veeva.com email address. 

Emergence

Veeva Systems

Targeted investment in non-promotional medical activities–such as congresses, publications, guidelines, clinical trials, and social media activity–prior to launch significantly accelerates treatment adoption.

However, some activities have more of an impact than others.

Read the full report: https://bit.ly/3LGOQxw

#medicalaffairs #veevapulse #pharma #medaffairs

Out today! New Veeva Pulse data reveals targeted pre-launch scientific outreach maximizes medical affairs teams’ impact on treatment adoption. Find how and learn more: https://lnkd.in/ggVpv2pM

#veevapulse #pharmaceuticals #lifesciences

For the first time in the industry, a Commercial Content Taxonomy for Life Sciences is being released, built from an in-depth analysis of 475+ configurations within Vault PromoMats. 

This global taxonomy is now publicly available to enhance content management efficiency and support industry-specific content technologies, including AI solutions.

The Commercial Content Taxonomy brings long-term benefits by:

✅ Preventing innovation from being hindered by customization
✅ Easing integrations
✅ Enhancing the end-user experience
✅ Making it simpler and more cost-effective 

Watch the video and download the Taxonomy here: https://bit.ly/4d7pQLw


#pharmaceuticals #contentstrategy

Ever wondered about the impact of non-promotional scientific activities on treatment adoption?

Curious which of the congresses, publications, guidelines, clinical trials, or social media activity is the biggest driver?

Answers to these and more in the new Veeva Pulse Field Trends Report: https://bit.ly/4bWrEpt

In the #manufacturing lab, bringing together test execution and sample management, improving right-first-time, and allowing review by exception can deliver access to key lab data faster. Veeva’s Jason Boyd explains how and why in Pharmaceutical Technology. https://lnkd.in/gRm4gX4S 

#qualitycontrol #qualityassurance

NYSE:VEEV

Veeva

Last Close

217.02

30/08 20:00

Market Cap

29.42B

Beta: 0.92

Volume Today

1.89M

Avg: 924.47K

PE Ratio

57.92

PFCF: 35.87

Financials Not Available